Forge Biologics, Inc
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Long-term Follow-up Study to Evaluate Safety and Efficacy of FBX-101 in Krabbe Patients (NCT06308718) | Forge Biologics, Inc | 2024-08-06 |
| Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT (NCT05739643) | Forge Biologics, Inc | 2023-02-03 |
| Gene Transfer Clinical Trial for Krabbe Disease (NCT04693598) | Forge Biologics, Inc | 2021-11-05 |
Track Forge Biologics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.